Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: A pilot study

Journal of Infectious Diseases

Volumn 181, Issue 6, 2000, Pages 1906-1910

  Spruance, Spotswood L ^a,b   McKeough, Mark B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FAMCICLOVIR; FLUOCINONIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; GASTROINTESTINAL SYMPTOM; HERPES LABIALIS; HUMAN; LUNG TOXICITY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; STEROID THERAPY; ULTRAVIOLET RADIATION;

2-AMINOPURINE; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FLUOCINONIDE; HERPES LABIALIS; HUMANS; MALE; PILOT PROJECTS; ULTRAVIOLET RAYS;

EID: 0034050931     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315528     Document Type: Article

References (22)

1. 1. Overall JC Jr. Dermatologic viral diseases. In: Galasso GJ, Merigan TC, Buchanan RA, eds. Antiviral agents and viral diseases of man. 2d ed. New York, NY: Raven Press, 1984:247-312.
2. 2. Spruance SL. Herpes simplex labialis. In: Sacks SL, Straus SE, Whitley RJ, Griffiths PD, eds. Clinical management of herpes viruses. Amsterdam, The Netherlands: IOS Press, 1995:3-42.
3. 3. Spruance SL, Stewart JCB, Freeman DJ, et al. Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial. J Infect Dis 1990;161: 191-7.
4. 4. Spruance SL, Stewart JCB, Rowe NH, McKeough MB, Wenerstrom G, Freeman DJ. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990;161:185-90.
5. 5. Raborn GW, McGaw WT, Grace M, Tyrrell LD, Samuels SM. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. J Am Dent Assoc 1987;115:38-42.
6. 6. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon K. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. JAMA 1997;277: 1374-9.
7. 7. Saez-Llorens X, McCracken GH. Antimicrobial and anti-inflammatory treatment of bacterial meningitis. Infect Dis Clin North Am 1999;13:619-36.
8. 8. MacFadden DK, Edelson JD, Hyland RH, Rodriguez CH, Inouye T, Rebuck AS. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1987;1:1477-9.
9. 9. Whitley RJ, Weiss H, Gnann JW Jr, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996;125:376-83.
10. 10. Spruance SL, Evans TG, McKeough MB, et al. Th1/Th2-like immunity and resistance to herpes simplex labialis. Antiviral Res 1995;28:39-55.
11. 11. Awan AR, Harmenberg J, Flink O, Field HJ. Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model. Antivir Chem Chemother 1998;9:19-24.
12. 12. Awan AR, Harmenberg J, Kristofferson A, Field HJ. Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease. Antiviral Res 1998;38:43-53.
13. 13. Spruance SL, Freeman DJ, Stewart JCB, et al. The natural history of ultraviolet radiation induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis 1991;163: 728-34.
14. 14. Bernstein DI, Schleupner CJ, Evans TG, et al. Effect of foscarnet cream on experimental UV radiation induced herpes labialis. Antimicrob Agents Chemother 1997;41:1961-4.
15. 15. Spruance SL, Rowe NH, Raborn GW, Thibodeau EA, D'Ambrosio JA, Bernstein DI. Peroral famciclovir in the treatment of experimental ultraviolet radiation induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis 1999;179: 303-10.
16. 16. Spruance SL, Schnipper LE, Overall JC Jr, et al. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis 1982; 146:85-90.
17. 17. Spruance SL. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol 1993;Suppl 1:27-32.
18. 18. Pitzalis C, Pipitone N, Bajocchi G, et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997;158:5007-16.
19. 19. Goulding NJ, Godolphin JL, Sharland PR, et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990;335:1416-8.
20. 20. Wang W, Wykrzykowska J, Johnson T, Sen R, Sen J. A NF-κ B/c-myc dependent survival pathway is targeted by corticosteroids in immature thymocytes. J Immunol 1999;162:314-22.
21. 21. Mori M, Pimpinelli N, Giannotti B. Topical Corticosteroids and unwanted local effects. Improving the benefit/risk ratio. Drug Saf 1994;10:406-12.
22. 22. Lundeen RC, Langlais RP, Terezhalmy GT. Sunscreen protection for lip mucosa: a review and update. J Am Dent Assoc 1985;111:617-21.